Therefore, inhibition of either STAT3/STAT5 signaling or PIM1/FATP2 expression in tumor-bearing mice in vitro could significantly attenuate MDSC-mediated immunosuppressive effects on tumors, thereby improving the anti-tumor response of CD8+ T-cells [227]. Here, CD8A is linked to neoplasm.